Jason R. Westin

The University of Texas MD Anderson Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

0.969Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A single-cell atlas of CD19 chimeric antigen receptor T cells

Cancer Cell(2023)10.1016/j.ccell.2023.08.015

Top 21%

0.969DataRank

Top 21%24 citations

Jared Henderson, Max J. Gordon, Irtiza Sheikh, Loretta J. Nastoupil, Jason R. Westin +8 more

Papers

Driven by 37 papers — median percentile 40. Top paper: “Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma”.

Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-21-0177

N/A

3.4DataRank · unranked

75 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma

Journal of Clinical Oncology(2022)10.1200/jco.22.00597

N/A

1.7DataRank · unranked

58 citations

R. Eric Davis, Lei Feng, Fredrick B. Hagemeister, Raphaël Steiner, Hun Ju Lee +24 more

Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(21)00638-0

N/A

1.5DataRank · unranked

56 citations

Preetesh Jain, Shuangtao Zhao, Hun Ju Lee, Loretta J. Nastoupil, Luis Fayad +32 more

Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma

Blood Advances(2022)10.1182/bloodadvances.2021006240

N/A

1.4DataRank · unranked

47 citations

Collin K. Chin, Jason R. Westin, Nathan Fowler, Felipe Samaniego, Xiaoyun Cheng +12 more

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

New England Journal of Medicine(2017)10.1056/nejmoa1707447

N/A

1.3DataRank · unranked

5812 citations

Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, David B. Miklos, Caron A. Jacobson +41 more

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of Clinical Oncology(2020)10.1200/jco.19.02104

N/A

0.997DataRank · unranked

767 citations

Michael D. Jain, Lei Feng, Jay Y. Spiegel, Armin Ghobadi, Yi Lin +23 more

A single-cell atlas of CD19 chimeric antigen receptor T cells

Cancer Cell(2023)10.1016/j.ccell.2023.08.015

Top 21%

0.969DataRank

Top 21%24 citations

Jared Henderson, Max J. Gordon, Irtiza Sheikh, Loretta J. Nastoupil, Jason R. Westin +8 more

Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial

The Lancet Haematology(2024)10.1016/s2352-3026(24)00133-9

N/A

0.833DataRank · unranked

29 citations

Jie Xu, Manoop S. Bhutani, Paolo Strati, Penny Q Fang, Susan Wu +22 more

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of Clinical Oncology(2024)10.1200/jco.23.02786

N/A

0.650DataRank · unranked

75 citations

Jay Y. Spiegel, Loretta J. Nastoupil, John Tamaresis, Armin Ghobadi, Yi Lin +27 more

A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL

Blood Advances(2022)10.1182/bloodadvances.2022008174

N/A

0.629DataRank · unranked

15 citations

Stefan Alig, Yasuhiro Oki, Loretta J. Nastoupil, Luis Fayad, Sattva S. Neelapu +16 more

Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8011

N/A

0.470DataRank · unranked

22 citations

Fateeha Furqan, Jason R. Westin, Luis Fayad, Sairah Ahmed, Hun Ju Lee +15 more

Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.3455

N/A

0.373DataRank · unranked

11 citations

Rishab Prakash, Paul Edelkamp, Mark Knafl, Anath C. Lionel, Ranjit Nair +94 more

Phased variants improve DLBCL minimal residual disease detection at the end of therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7565

N/A

0.348DataRank · unranked

3 citations

Jacob J. Chabon, Joanne Soo, Lyron Co Ting Keh, Stefan Alig, André Schultz +15 more

Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy

Haematologica(2023)10.3324/haematol.2023.284453

N/A

0.284DataRank · unranked

4 citations

Naishu Kui, Ryan Sun, Jason R. Westin, Raphaël Steiner, Ranjit Nair +16 more

A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma

Blood Advances(2025)10.1182/bloodadvances.2025016483

N/A

0.241DataRank · unranked

4 citations

Lei Feng, Jason R. Westin, Fredrick B. Hagemeister, Hun Ju Lee, Luis Fayad +16 more

Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?

Advances in Radiation Oncology(2024)10.1016/j.adro.2024.101650

N/A

0.104DataRank · unranked

1 citations

Sonal S. Noticewala, Susan Wu, Jillian R. Gunther, Ethan B. Ludmir, L. Jeffrey Medeiros +15 more

Impact of Pre-Treatment Liver-Related Factors on Clinical Outcomes after CAR T-Cell Therapy for Lymphoma

Blood(2024)10.1182/blood-2024-207616

N/A

0DataRank · unranked

1 citations

Sushanth Gouni, Lei Feng, Charles Gaulin, Amrit S. Gonugunta, Turçin Saridogan +22 more

Acalabrutinib with Rituximab Is Highly Effective First Line Treatment for Older Patients with Mantle Cell Lymphoma

Blood(2024)10.1182/blood-2024-206042

N/A

0DataRank · unranked

1 citations

Chi Young Ok, Jason R. Westin, Holly A. Hill, Ranjit Nair, Swaminathan P. Iyer +28 more

Peripheral Blood CAR T-Cell Level Using a Clia-Validated Assay Is Prognostic for Treatment Response and Icans in Large B-Cell Lymphoma

Blood(2024)10.1182/blood-2024-208300

N/A

0DataRank · unranked

0 citations

Naishu Kui, Ryan Sun, Eslam Aboismail, Sanjit O. Tewari, Ajlan Al Zaki +26 more

Interim PET-Adapted De-Escalation Chemotherapy Regimen for Advanced Stage Classical Hodgkin Lymphoma Using Brentuximab Vedotin, Pembrolizumab, Doxorubicin, and Dacarbazine: Phase 2 Safety and Efficacy Study

Blood(2024)10.1182/blood-2024-212005

N/A

0DataRank · unranked

0 citations

Gregory Ravizzini, Eslam Aboismail, Jenna M. Wixom, Jared Henderson, Luis Fayad +11 more

Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial

Nature Communications(2025)10.1038/s41467-025-62509-z

N/A

0DataRank · unranked

4 citations

Lei Feng, Jason R. Westin, Ranjit Nair, Luis Fayad, Maria Alma Rodriguez +14 more

Germline determinants of toxicity and efficacy in patients with large B-cell lymphoma treated with CAR T-cell therapy

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012401

N/A

0DataRank · unranked

0 citations

Amanda Brandt, Anath C. Lionel, Jared Henderson, Jason R. Westin, Sherry Adkins +9 more

Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphoma

Blood Advances(2020)10.1182/bloodadvances.2020002328

N/A

0DataRank · unranked

197 citations

Sairah Ahmed, Partow Kebriaei, Loretta J. Nastoupil, Catherine M. Claussen, Grace Watson +10 more

Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.13935

N/A

0DataRank · unranked

12 citations

Jillian R. Gunther, Penny Fang, Mikaela Bankston, Sarah A. Milgrom, David Boyce-Fappiano +14 more

Primary CNS lymphoma commonly expresses immune response biomarkers

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa018

N/A

0DataRank · unranked

36 citations

Ashley Sumrall, Surasak Phuphanich, David Spetzler, Zoran Gatalica, Joanne Xiu +9 more

Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET–CT-documented First Remission

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.02.008

N/A

0DataRank · unranked

5 citations

Jillian R. Gunther, Penny Fang, Sarah A. Milgrom, Brinda Rao Korivi, Corey T. Jensen +16 more

CARDIOVASCULAR EVENTS AMONG ADULT PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA TREATED WITH STANDARD OF CARE AXICABTAGENE CILOLEUCEL AND TISAGENLECLEUCEL

Hematological Oncology(2021)10.1002/hon.177_2880

N/A

0DataRank · unranked

0 citations

José Banchs, Efstratios Koutroumpakis, Melody Becnel, Cristina Gutiérrez, Paolo Strati +14 more

Clonal hematopoiesis is associated with increased toxicity in large B-cell lymphoma patients treated with chimeric antigen receptor T cell therapy

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.28.461858

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Jungsheng Ma, Romil Patel, Kartik Devashish +32 more

Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response

Haematologica(2022)10.3324/haematol.2022.281954

N/A

0DataRank · unranked

15 citations

Sushanth Gouni, Jason R. Westin, Lei Feng, Haleigh Mistry, Raphaël Steiner +16 more

A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023010653

N/A

0DataRank · unranked

44 citations

Andrew Jallouk, Qing Deng, Xubin Li, Lei Feng, Ryan Sun +23 more

The race is on: bispecifics vs CAR T cells in B-cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022009066

N/A

0DataRank · unranked

21 citations

Jason R. Westin, Marion Subklewe, Ashwath Gurumurthi

Six Years Follow up of Ibrutinib Plus Rituximab (IR) Followed By Short Course R-Hyper CVAD/MTX in Patients (age ≤ 65 years) with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-1 Clinical Trial

Blood(2023)10.1182/blood-2023-181312

N/A

0DataRank · unranked

1 citations

Hun Ju Lee, Jason R. Westin, Loretta J. Nastoupil, Luis Fayad, Ranjit Nair +14 more

Data from Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression

(2023)10.1158/2643-3230.c.6550995

Top 100%

0DataRank

Top 100%0 citations

Qing Deng, Mario L. Marques‐Piubelli, Enyu Dai, Minghao Dang, Man Chun John +29 more

Data from Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

(2023)10.1158/2643-3230.c.6550812.v1

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHL

Blood Advances(2024)10.1182/bloodadvances.2023011040

N/A

0DataRank · unranked

6 citations

Clark R. Andersen, Amy Ayers, Jason R. Westin, Michael Wang, Swaminathan P. Iyer +10 more

Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B‐cell lymphoma after 2 or more lines of prior therapy

American Journal of Hematology(2024)10.1002/ajh.27283

N/A

0DataRank · unranked

4 citations

Hailin Wang, Zhen‐Huan Hu, Frederick L. Locke, Tanya Siddiqi, Caron A. Jacobson +18 more

Phase II Trial of Axicabagene Ciloleucel and Glofitamab As Second-Line Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma

Blood(2024)10.1182/blood-2024-205196

N/A

0DataRank · unranked

4 citations

Dai Chihara, Luis Fayad, Sattva S. Neelapu, Sairah Ahmed, Frederick Hagemeister +11 more

Jason R. Westin

Indexed papers

Top data-sharing exemplar

Papers